This study aims to describe the neuropsychological profile of a clinical sample of drug -dependent women to treatment in a drug dependency. A battery of neuropsychological evaluation was applied to an intentional sample composed of 25 drug-dependent women with subjective complaints of attention and / or memory, who were referred to the area of neuropsychology of the Drug Dependency Unit of the Concello de Vigo CEDRO (Galicia, Spain). The scores related to the cognitive / executive functioning of the sample are indicative of difficulties in visuospatial processing speed (M = 43.79, SD = 14.88) The use of psychoactive substances has been consistently associated with the presence of alterations in different neuropsychological processes: memory, attention or executive functions [4][5][6][7][8].Most studies carried out in the drug-dependent population are mostly or exclusively male [9], and few studies have analyzed gender differences, although this aspect is of great relevance for the knowledge of the different disorders, As expressed in the guidelines for the development of future diagnostic classifications.In the current 2013-2016 Action Plan, the importance of the gender focus for specific attention to drug-dependent women (National Plan on Drugs, 2013a) is highlighted on multiple occasions. These proposals reflect a need already demanded in theoretical and research papers that demonstrate the existence of differences between women and men in terms of drug use and their psychological intervention, often using a traditional nonspecific intervention model.Physiologically it is known that women tend to have a more rapid development of the symptoms associated with dependence, arriving at treatment with less years of consumption and with more severe symptoms and that the neurotoxic effects of Cocaine can cause more CNS damage in men than in women.The presence of dual pathology and the severity of psychiatric symptomatology make it difficult to treat drug dependence, which indicates the need to simultaneously detect and treat both disorders [10]. The mortality risk attributable to dual pathology has been found to be significantly higher in women than in men and that women appear to be more vulnerable to presenting psychotic symptoms faster than men.Taking into account epidemiological data in relation to consumption in Spain, the differences between men and women are becoming smaller, with only women emphasizing the consumption of psychoactive drugs.There is evidence of high variability in response to methadone treatment among patients indicating that they may have different treatment needs. Men and women in particular are known to differ in susceptibility to addiction and behavior, including the age of first use of opiates, progress to regular use and age of admission treatment. Men and women are also likely to differ in methadone treatment outcomes, although the differences are not clear in the literature. Therefore, current standards of treatment that offer